More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Years

Watchdoq November 19, 2024
(MedPage Today) -- Lipoprotein(a), or Lp(a), was successfully reduced in phase II trials of muvalaplin and zerlasiran. (JAMA)
The possibility of a drug interaction between SGLT2 inhibitors and statins was not supported by rates of rhabdomyolysis...

Read Full Article